anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

11,701-11,760 of 319,975

filter-aware
30
Team bio slide with contact details and office locations.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting 1 hit
31
Hospital Priorities 2022 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting 1 hit
01
Slide 1
Hospital Priorities 2023 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting 1 hit
02
The slide uses stacked bar charts to visualize the composition of the survey sample.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Situation & Context1 hit
03
NRDL=National Reimbursement Drug List; VBP=volume-based procurementHospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Situation & Context1 hit
04
The table includes bilingual (English/Chinese) labels for spending categories.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
05
The chart highlights top priorities for hospitals regarding pharma support, with a specific callout regarding NRDL negotiation and VBP impact on drug costs.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
06
Data from L.E.K. 2023 APAC Hospital Priorities Survey (N=100).Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
07
The slide uses a consistent color-coded legend for years (2021, 2022, 2023) across three bar charts.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
08
NRDL = National Reimbursement Drug List. Data from L.E.K. APAC Hospital Priorities Survey.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
09
The slide uses a stacked bar chart approach to visualize survey data regarding prescription outflow shifts.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
10
The chart shows a clear shift toward higher acceptance of digital engagement in 2023 compared to 2022 across all hospital segments.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
11
The slide uses a bilingual (Chinese/English) format for labels.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
12
Includes a specific callout explaining a spike in privacy concerns due to China's PIPL law.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
13
The slide uses a stacked bar chart approach to visualize survey responses regarding financial health.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
14
The slide uses a numbered list to structure key strategic inquiries.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Aha Moment1 hit
15
Hospital Priorities 2023 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
16
The slide uses a bilingual (English/Chinese) table format to present survey results from 100 respondents.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
17
The slide uses color coding to categorize priorities into Pandemic response, Workflow efficiency, and Care management capability.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
18
The table uses a 1-7 scale for survey responses; percentages represent respondents choosing 6 or 7.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
19
The slide uses a stacked bar chart approach to rank specialties by preference within each hospital category.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
20
The chart is a dot plot comparing three segments (Public L3, Public L2, Private) across 7 value drivers.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
21
Includes bilingual labels (English/Chinese).Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
22
The slide uses a central circular focal point 'Insights with Impact' to bridge the firm's expertise and analytical rigor with its sector and service focus.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting 1 hit
23
The slide uses a matrix-like structure to show vertical industry segments and horizontal functional/thematic practices.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting 1 hit
24
Hospital Priorities 2023 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting 1 hit
25
Hospital Priorities 2023 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting 1 hit
01
Slide 1
Impact of the US BIOSECURE Act on Biopharmas, Contract Services and InvestorsImpact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
02
The slide provides a methodological overview of the survey sample, including familiarity, geography, sector, and functional role of respondents.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
03
The slide highlights the timing of an L.E.K. survey relative to the legislative process.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
04
Impact of the US BIOSECURE Act on Biopharmas, Contract Services and InvestorsImpact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
05
Impact of the US BIOSECURE Act on Biopharmas, Contract Services and InvestorsImpact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
06
The chart uses a grouped bar format to compare 'Before' and 'After' confidence scores (0-10 scale) with percentage change annotations.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
07
The chart uses a multi-select survey format, so percentages may not sum to 100%.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
08
The chart uses a custom layout with a central axis and directional arrows to indicate sentiment/impact.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
09
The chart displays multi-select survey data.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
10
The chart displays survey results regarding the impact of the US BIOSECURE Act on partnering intentions.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
11
The slide uses a matrix-like structure to show vertical industry sectors and horizontal functional capabilities.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next Steps1 hit
12
Impact of the US BIOSECURE Act on Biopharmas, Contract Services and InvestorsImpact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next Steps1 hit
13
Impact of the US BIOSECURE Act on Biopharmas, Contract Services and InvestorsImpact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting 1 hit
01
Slide 1
Infrastructure beyond COVID-19Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
02
Infrastructure beyond COVID-19Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
03
Infrastructure beyond COVID-19Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
04
The slide serves as an introduction to an interim report for the 2021 Australian Infrastructure Plan.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
05
The slide uses a structured grid layout to present trends, metrics, and implications.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
06
The slide uses a grid layout to present six distinct thematic opportunities.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
07
The slide uses a grid layout to present six distinct problem statements.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
08
The slide uses a three-column layout to categorize sector-specific impacts.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
09
Infrastructure beyond COVID-19Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
10
Infrastructure beyond COVID-19Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
11
The slide uses a matrix structure to categorize qualitative impacts across sectors. It includes a legend for impact intensity.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
12
Infrastructure beyond COVID-19Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
13
The slide serves as an introduction/purpose statement for the report.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit
14
The slide lists numerous organizations and data sources used for the market data and secondary research.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit
15
The framework is split into 'Current Assessment' (steps 1-3) and 'Future Sensitivity' (step 4).Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit
16
The slide uses a 2x2 matrix to define four quadrants (A, B, C, D) representing different recovery outcomes.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit
17
Infrastructure beyond COVID-19Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit
18
The slide uses a multi-phase timeline framework to contextualize historical performance and future uncertainty.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit
19
The slide uses a line chart to contrast Australia's containment success against the multi-wave patterns in other major nations.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit
20
Infrastructure beyond COVID-19Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit